Abstract 250P
Background
It is widely believed that nutritional and psychological disorders can affect the outcome of cancer treatment and the life quality of patients. However, the importance of nutritional and psychological interventions is still underestimated, and cancer treatment remains the main focus of clinical practice. In order to raise awareness of clinicians, we conducted a survey of nutritional and psychological status of cancer patients.
Methods
From December 2020 to January 2022, 1000 patients with advanced cancer completed the online survey of stardard nutritional and psychological scales.
Results
All the patients had solid tumors, and most(84.1%) of them had trouble in life quality caused by cancer treatment. The survey indicated 74.7% of the patients had at least once nutritional risk. Psychological disorders referred to three terms including insomnia, anxiety and depression. Patients experienced mild, moderate and severe insomnia was respectively 48.2%, 18.5% and 1.5%; mild, moderate and severe anxiety was respectively 57.5%, 25.5% and 3.3%; mild, moderate and severe depression was respectively 20.7%, 9.5% and 2.3%. Surprising 92.7% of the patients had never received any nutritional or psychological intervention.
Conclusions
There is an urgent need to assess the nutritional and psychological status of cancer patients in the early stage of treatment, and implement effective interventions to enable more patients to live longer and better.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
150P - Use of neoadjuvant chemotherapy for non-metastatic muscle-invasive bladder cancer in Asia-Pacific
Presenter: Ravindran Kanesvaran
Session: Poster viewing 03
Resources:
Abstract
Slides
151P - Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer: Real-world analysis of chemotherapy use and impact on patient outcomes
Presenter: Alison Hiong
Session: Poster viewing 03
152P - An epidemiologic study on PD-L1 expression with clinical observation of initial treatment pattern in the Chinese muscle invasive urothelial bladder carcinoma patients
Presenter: Liqun Zhou
Session: Poster viewing 03
153P - Efficacy and toxicity of HER2-targeted antibody-drug conjugates (ADCs) in the treatment of metastatic urothelial cancer (mUC): A systematic review
Presenter: Tiago Padua
Session: Poster viewing 03
154P - Can urine cytology predict variants of bladder cancer?
Presenter: Hikaru Mikami
Session: Poster viewing 03
155P - Search for circulating tumor cells in patients with urothelial cancer
Presenter: Irina Kruglova
Session: Poster viewing 03
156P - The association between response to enfortumab vedotin therapy and primary tumor location in Japanese urothelial carcinoma patients
Presenter: Nozomi Hayakawa
Session: Poster viewing 03
163P - Outcomes and toxicity of fosfesterol in metastatic castration-resistant prostate cancer: Experience from a low middle income country
Presenter: Manuprasad Avaronnan
Session: Poster viewing 03
164P - F-18 PSMA-PET/CT-guided percutaneous prostate biopsy
Presenter: Rajender Kumar
Session: Poster viewing 03
165P - Real-world utilisation of upfront chemohormonal therapy in metastatic hormone-sensitive prostate cancer
Presenter: Richard Kelly
Session: Poster viewing 03